This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Epidemiology

Authoring team

  • average frequency of new patient per GP - one in every five years

  • with respect to adults aged 15+ years in England and Wales in 1992 - the total new cases was 5,384 and the number per annum per 2000 population was 0.21 (1)

  • there is a palpable pelvic mass in 90% (1)

  • generally diagnosed late

  • symptoms are generally vague - non-specific/vague abdominal symptoms

  • the outcome for women with ovarian cancer is generally poor, with an overall 5 year survival rate of less than 35% (2)

  • despite the relatively poor overall survival rates for ovarian cancer, there has been a two-fold increase in survival over the last 30 years. This has coincided with the advent of effective chemotherapy, and the introduction of platinum-based agents in particular, as well as changes in surgical practice (2)

  • the risk of development of ovarian cancer with respect to other families affected is described in the linked item

Ovarian carcinoma has a lifetime incidence of about 0.97%. This compares with carcinoma of the cervix, endometrium and breast which have lifetime incidences of 1.29%, 1.02% and 5.11% respectively. Ovarian carcinoma has a mean age of incidence of 58 years and usually occurs between the 3rd and 8th decades.

Reference:

  • 1) Referral Guidelines for Suspected Cancer (April 2000). NHS Executive.
  • 2) NICE (March 2011). Ovarian cancer The recognition and initial management of ovarian cancer
  • 3) Pulse (21/8/99), 30.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.